Blueberry THC Distillate is manufactured via an advanced multi-stage isolation process engineered to concentrate Delta-9-Tetrahydrocannabinol while completely stripping away non-therapeutic ballast, including chlorophyll, plant lipids, waxes, and volatile solvents. Initial raw crude oil is extracted utilizing sub-zero cryogenic ethanol, followed by multi-stage winterization and sub-micron filtration to achieve high clarirty. The purified extract undergoes controlled thermal vacuum decarboxylation prior to fractional wiped-film short-path distillation, separating cannabinoid fractions under high vacuum to produce a pure, golden cannabinoid resin.
Following distillation, the ultra-pure distillate is homogenously blended with a standardized 3.0% to 5.0% natural Blueberry terpene profile dominated by Beta-Myrcene, Beta-Caryophyllene, and Linalool. This precise formulation ensures organoleptic batch-to-batch reproducibility, optimizes fluid dynamics for medical vaporizers, and supports clinical therapeutic efficacy through the entourage effect. Across European medical cannabis frameworks—notably Germany under the CanG framework, the United Kingdom, and Poland—Blueberry THC Distillate is widely prescribed for nocturnal pain relief, sleep-onset insomnia, palliative oncology support, and severe muscular spasms.
Technical Specifications & Certificate of Analysis (CoA)
| Specification | Standard / Analytical Value |
| Active Pharmaceutical Ingredient | Standardized Delta-9-Tetrahydrocannabinol (Δ9-THC) |
| Physical Appearance | Viscous, translucent amber-gold oil |
| THC Potency (Δ9-THC) | 85.0% – 92.0% w/w |
| CBD Potency | < 1.0% w/w |
| Minor Cannabinoids | CBG (1.0% – 2.4%), CBN (< 1.5%), CBC (< 0.8%), THCV (< 0.5%) |
| Primary Terpenes | Beta-Myrcene, Beta-Caryophyllene, Alpha-Pinene, Linalool |
| Total Added Terpenes | 3.0% – 5.0% w/w (Batch Standardized) |
| Residual Solvents | Below Limit of Quantitation (Ph. Eur. 2.4.24) |
| Pesticide Residues | Non-detectable (Ph. Eur. 2.8.13) |
| Heavy Metals | Pb ≤ 0.5 ppm, Cd ≤ 0.5 ppm, Hg ≤ 0.1 ppm, As ≤ 0.5 ppm (Ph. Eur. 2.4.27) |
| Microbiological Purity | Total Aerobic Microbial Count (TAMC) < 10² CFU/g, TYMC < 10¹ CFU/g (Ph. Eur. 5.1.8) |
| Manufacturing Standard | EU-GMP Part II (Active Pharmaceutical Ingredients) |
| Pharmacopoeial Monograph | Ph. Eur. Monograph Cannabis Extract / DAB Standardized Extract |
Sensory & Terpene Profile Breakdown
-
Macerated Wild Blueberries & Sweet Jam: A high concentration of Beta-Myrcene paired with natural fruit esters delivers an upfront aromatic profile of ripe blueberries, blackberry nectar, and sweet fruit syrup.
-
Warm Spiced Cedar & Earthy Hash: Beta-Caryophyllene provides an earthy, warm woody back-note with subtle cracked peppercorn that anchors the sweet berry profile.
-
Floral Lavender & Soft Botanicals: Linalool lends a calming, subtle floral note reminiscent of fresh lavender blossoms, contributing to a smooth vaporization experience.
-
Crisp Herbal Pine: Alpha-Pinene introduces a cooling conifer sharpness on the finish, enhancing respiratory comfort upon inhalation.
-
Viscosity & Rheology: High-density, viscous resin at ambient room temperature (20°C–25°C), flowing smoothly when mildly warmed (40°C–50°C) for pharmacy dispensing, compounding, or cartridge filling.
European Compliance, Quality Assurance & Distribution
-
EU-GMP Part II Certified Manufacturing: Extracted, refined, and formulated in certified pharmaceutical cleanrooms operating strictly under EU-GMP Part II standards for Active Pharmaceutical Ingredients (APIs), ensuring comprehensive process validation and prevention of cross-contamination.
-
Accredited Laboratory Testing: Every production lot is analyzed by third-party ISO/IEC 17025 accredited laboratories, providing validated batch-specific CoAs covering cannabinoid quantification, terpene composition, residual solvents (Ph. Eur. 2.4.24), heavy metals, and full microbial bioburden panels.
-
Schengen Cross-Border Logistics: Supported by an end-to-end regulatory compliance pack, including Wholesale Distribution Authorizations (WDA), Active Pharmaceutical Ingredient (API) registration files, GMP declarations, and validated bilateral narcotics import/export licenses across EU member states.
-
Pharmaceutical Packaging: Supplied in tamper-evident, medical-grade borosilicate glass containers, fluoropolymer-lined containers, or 316L pharmaceutical stainless steel vessels sealed under an inert argon or nitrogen blanket to eliminate oxidative degradation during storage and transit.

